PetMeds Q1 FY27 net loss narrows to $6.1 million; net sales fall 19.9% to $41 million
PETS•Quarterly results
PetMed Express posted a Q1 net loss of $6.1 million, or $0.28 per share, narrowing from a year earlier.
Net sales fell 19.9% year over year to $41 million on lower promotional usage and a decline in prescription medication sales.
Adjusted EBITDA loss, on a non-GAAP basis, widened to $3.4 million from a year earlier.
Operational update
The company said its technology transformation is advancing with an enterprise-wide rollout of a new SAP ERP system.
Marketing efficiency improved, with PetMeds adding 70,000 new customers while cutting new-customer acquisition cost 15% year over year.
